
Marjorie Taylor Greene Periodic Transaction Report
Filed Aug 20, 2025 · House Clerk · 1 transaction
U.S. Representative · R · GA-14 · All trades by Marjorie Taylor Greene
On August 20, 2025, Rep. Marjorie Taylor Greene (R-GA-14) filed a periodic transaction report with the House Clerk disclosing 1 transaction (1 purchase) dated Aug 19, 2025.
The filing covers 1 ticker, including $NVO.
Reported amount ranges sum to $15K–$50K. Congress reports trade sizes in ranges, not exact figures.
Every trade was reported within the STOCK Act's 45-day window. The longest lag in this filing was 1 day.
Source document: House Clerk filing 20030944
Sample · the intelligence layer
Marjorie Taylor Greene · Bought $NVO · Aug 19 · $15K–$50K
1 other member traded this name in the same window.
Coldpine’s read
Greene's purchase of Novo Nordisk, maker of GLP-1 drugs Ozempic and Wegovy, was disclosed within one day, a fast turnaround that means the market may not have absorbed the filing. At least one other member traded the same name in the same direction within 30 days, indicating some cluster activity. The $15,001–$50,000 range is consistent with her typical individual equity purchases.
Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →
Follow Marjorie Taylor Greene
Get an email the moment Marjorie Taylor Greene files the next one. Free, no card, no spam.
Tickers in this filing
Transactions disclosed
| Trade date | Ticker | Asset | Type | Owner | Amount | Lag |
|---|---|---|---|---|---|---|
| Aug 19, 2025 | NVONVONovo Nordisk A/S Common Stock | Novo Nordisk A/S Common Stock (NVO) | buy | — | $15K–$50K | 1d |
Other recent filings by Marjorie Taylor Greene
- PTR filed Dec 16, 20251 trade
- PTR filed Dec 2, 20251 trade · IBIT
- PTR filed Nov 19, 20251 trade
- PTR filed Nov 13, 20252 trades · ADP, PAYX
- PTR filed Nov 7, 20251 trade · PG
- PTR filed Oct 28, 202514 trades · AMGN, AMZN, BRK.B, BX
← All congressional filings, newest first
From Coldpine Research
Data parsed from the public STOCK Act filing linked above. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. Nothing here is a recommendation. See scores and Coldpine's read on every trade, free with an account →